neomycin-polymyxin b-dexamethasone opht brand names and other generic formulations include:
Ak-trol Opht, Cpc Optic Opht, Dexa/neo/poly Opht, Dexacidin Opht, Dexacine Opht, Dexasporin Opht, Dex-gen Opht, Dex-ide Opht, Infa-trol Opht, Infectrol Opht, Maxitrol Opht, Methadex Opht, Neo Poly B Sulf Dex Opht, Neo Poly Dex Opht, Poly-dex Opht, Spectro-max Opht, Storz-n-p-d Opht, W-dnp Opht
elvitegravir-cobicist-emtricitab-tenofovir alafenamide oral brand names and other generic formulations include:
Genvoya Oral
neomycin-polymyxin b-dexamethasone opht and elvitegravir-cobicist-emtricitab-tenofovir alafenamide oral
neomycin-polymyxin b-dexamethasone opht will decrease the level or effect of elvitegravir-cobicist-emtricitab-tenofovir alafenamide oral by altering drug metabolism. Avoid this combination. Blood levels of elvitegravir may be reduced decreasing effectiveness.
neomycin-polymyxin b-dexamethasone opht and elvitegravir-cobicist-emtricitab-tenofovir alafenamide oral
neomycin-polymyxin b-dexamethasone opht will decrease the level or effect of elvitegravir-cobicist-emtricitab-tenofovir alafenamide oral by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid; coadministration with CYP3A inducers may result in decreased plasma concentrations of elvitegravir and/or a concomitantly administered protease inhibitor and lead to loss of therapeutic effect and to possible resistance
Check for more interactions with the Drug Interaction Checker
Drug Interaction Categories
Contraindicated
Never use this combination of drugs because of high risk for dangerous interaction
Serious
Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed
Significant
Potential for significant interaction (monitoring by your doctor is likely required)
Minor
Interaction is unlikely, minor, or nonsignificant